Table 2.
Overall Survival | |||
---|---|---|---|
N = 231 | 5 Years (%) | P value | |
Age | 0.08 | ||
> 60 | 123 | 50.3 | |
≤ 60 | 108 | 36.4 | |
Sex | 0.56 | ||
Male | 198 | 42.5 | |
Female | 33 | 40.9 | |
Primary site | < 0.01* | ||
Group 1 | 40 | ||
Nasopharynx | 3 | NA | |
Oropharynx | 30 | 51.9 | |
Salivary gland | 7 | 55.6 | |
Group 2 | 69 | ||
Oral Cavity | 12 | 36.7 | |
Tongue | 45 | 24.9 | |
Paranasal sinus | 12 | 14.3 | |
Group 3 | 122 | ||
Hypopharynx | 55 | 34.6 | |
Larynx | 67 | 57.2 | |
DFI (months) | 0.09 | ||
≤ 24 | 131 | 37.1 | |
> 24 | 100 | 50.0 | |
Pathological maximum diameter (mm) | < 0.01* | ||
≤ 20 | 121 | 52.6 | |
> 20 | 110 | 31.6 | |
Procedures | 0.17 | ||
Sublobar | 134 | 44.8 | |
Lobectomy or more | 95 | 40.3 | |
Unknown | 2 | ||
Side | 0.63 | ||
Either | 212 | 42.1 | |
Bilateral | 19 | 44.9 | |
Number | 0.58 | ||
Solitary | 181 | 42.4 | |
Multiple | 50 | 42.6 |
Note: *p < 0.05: indicates significant values.
Abbreviations: DFI, disease-free interval; NA, not available.